Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for Compass Therapeutics (CMPX) over the last 6 years, with Dec 2024 value amounting to -$56.6 million.

  • Compass Therapeutics' Consolidated Net Income fell 29.23% to -$15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$70.1 million, marking a year-over-year decrease of 41.55%. This contributed to the annual value of -$56.6 million for FY2024, which is 33.25% down from last year.
  • Per Compass Therapeutics' latest filing, its Consolidated Net Income stood at -$56.6 million for FY2024, which was down 33.25% from -$42.5 million recorded in FY2023.
  • Over the past 5 years, Compass Therapeutics' Consolidated Net Income peaked at -$37,483 during FY2020, and registered a low of -$82.2 million during FY2021.
  • For the 3-year period, Compass Therapeutics' Consolidated Net Income averaged around -$46.1 million, with its median value being -$42.5 million (2023).
  • Per our database at Business Quant, Compass Therapeutics' Consolidated Net Income crashed by 178.58% in 2021 and then surged by 52.27% in 2022.
  • Over the past 5 years, Compass Therapeutics' Consolidated Net Income (Yearly) stood at -$37,483 in 2020, then climbed by 15.09% to -$29.5 million in 2020, then slumped by 178.58% to -$82.2 million in 2021, then spiked by 52.27% to -$39.2 million in 2022, then dropped by 8.33% to -$42.5 million in 2023, then tumbled by 33.25% to -$56.6 million in 2024.